Found: 31
Select item for more details and to access through your institution.
Optimal strategies for preventing progression of renal disease: Should angiotensin converting enzyme inhibitors and angiotensin receptor blockers be used together?
- Published in:
- Current Hypertension Reports, 2000, v. 2, n. 5, p. 465, doi. 10.1007/s11906-000-0029-8
- By:
- Publication type:
- Article
Effects of ACE inhibition and AT1-receptor blockade on haemodynamic responses to L-arginine in Type 1 diabetes.
- Published in:
- Journal of the Renin-Angiotensin-Aldosterone System, 2004, v. 5, n. 1, p. 33, doi. 10.3317/jraas.2004.006
- By:
- Publication type:
- Article
Gender hormones and the progression of experimental polycystic kidney disease.
- Published in:
- Kidney International, 2005, v. 68, n. 4, p. 1729, doi. 10.1111/j.1523-1755.2005.00589.x
- By:
- Publication type:
- Article
Renal cyclooxygenase-2 in obese Zucker (fatty) rats.
- Published in:
- Kidney International, 2005, v. 67, n. 6, p. 2151, doi. 10.1111/j.1523-1755.2005.00320.x
- By:
- Publication type:
- Article
Endothelial-derived vasoactive mediators in polycystic kidney disease.
- Published in:
- Kidney International, 2003, v. 63, n. 5, p. 1776, doi. 10.1046/j.1523-1755.2003.00913.x
- By:
- Publication type:
- Article
miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7.
- Published in:
- Clinical Science, 2015, v. 129, n. 12, p. 1237, doi. 10.1042/CS20150427
- By:
- Publication type:
- Article
Renin inhibition in the treatment of diabetic kidney disease.
- Published in:
- Clinical Science, 2013, v. 124, n. 9, p. 553, doi. 10.1042/CS20120468
- By:
- Publication type:
- Article
Enhanced phosphorylation of Na<sup>+</sup> -Cl<sup>-</sup> co-transporter in experimental metabolic syndrome: role of insulin.
- Published in:
- Clinical Science, 2012, v. 123, n. 11, p. 635, doi. 10.1042/CS20120003
- By:
- Publication type:
- Article
Maximizing the value of the open label extension phase of randomized clinical trials.
- Published in:
- Journal of Nephrology (JNonline), 2023, v. 36, n. 6, p. 1561, doi. 10.1007/s40620-022-01542-3
- By:
- Publication type:
- Article
Effect of orchiectomy on renal function in control and diabetic rats with chronic inhibition of nitric oxide.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2010, v. 37, n. 1, p. 19, doi. 10.1111/j.1440-1681.2009.05206.x
- By:
- Publication type:
- Article
CYCLO-OXYGENASE-2 INHIBITION ATTENUATES THE PROGRESSION OF NEPHROPATHY IN UNINEPHRECTOMIZED DIABETIC RATS.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2007, v. 34, n. 1/2, p. 36, doi. 10.1111/j.1440-1681.2007.04534.x
- By:
- Publication type:
- Article
EFFECT OF HYPERINSULINAEMIA ON RENAL FUNCTION AND NITRATE/NITRITE EXCRETION IN HEALTHY SUBJECTS*.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 1999, v. 26, n. 4, p. 336, doi. 10.1046/j.1440-1681.1999.03038.x
- By:
- Publication type:
- Article
What is the role of renin inhibition in the treatment of diabetic kidney disease?
- Published in:
- Current Diabetes Reports, 2009, v. 9, n. 6, p. 447, doi. 10.1007/s11892-009-0073-y
- By:
- Publication type:
- Article
Treatment of hypertension in diabetic patients with nephropathy.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Dual inhibition of the endothelin and angiotensin receptor ameliorates renal and inner ear pathologies in Alport mice.
- Published in:
- Journal of Pathology, 2023, v. 260, n. 3, p. 353, doi. 10.1002/path.6087
- By:
- Publication type:
- Article
Rho kinase inhibition in diabetic kidney disease.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 76, p. 551, doi. 10.1111/bcp.12196
- By:
- Publication type:
- Article
Rho kinase inhibition in diabetic kidney disease.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 76, n. 4, p. 551, doi. 10.1111/bcp.12196
- By:
- Publication type:
- Article
Transcriptome-Based Analysis of Kidney Gene Expression Changes Associated with Diabetes in OVE26 Mice, in the Presence and Absence of Losartan Treatment.
- Published in:
- PLoS ONE, 2014, v. 9, n. 5, p. 1, doi. 10.1371/journal.pone.0096987
- By:
- Publication type:
- Article
Mechanism of protective actions of sparsentan in the kidney: lessons from studies in models of chronic kidney disease.
- Published in:
- Clinical Science, 2024, v. 138, n. 11, p. 645, doi. 10.1042/CS20240249
- By:
- Publication type:
- Article
Renal Effects of HMG-CoA Reductase Inhibition in a Rat Model of Chronic Inhibition of Nitric Oxide Synthesis.
- Published in:
- Kidney & Blood Pressure Research, 2006, v. 29, n. 3, p. 135, doi. 10.1159/000094988
- By:
- Publication type:
- Article
The Increased Activity of Liver Lysosomal Lipase in Nonalcoholic Fatty Liver Disease Contributes to the Development of Hepatic Insulin Resistance.
- Published in:
- Biotechnology Research International, 2012, p. 1, doi. 10.1155/2012/135723
- By:
- Publication type:
- Article
Rho kinase inhibition protects kidneys from diabetic nephropathy without reducing blood pressure.
- Published in:
- Kidney International, 2011, v. 79, n. 4, p. 432, doi. 10.1038/ki.2010.428
- By:
- Publication type:
- Article
Inhibition of the renin–angiotensin system: is more better?
- Published in:
- 2009
- By:
- Publication type:
- Editorial
The Effect of Telmisartan on Selected Plasma Adipoeytokines and their Expressions in Subcutaneous Adipose Tissue in Patients with High Risk of Diabetes.
- Published in:
- Diabetes, 2007, v. 56, p. A513
- By:
- Publication type:
- Article
Altered Endothelial Nitric Oxide Synthase Targeting and Conformation and Caveolin-1 Expression in the Diabetic Kidney.
- Published in:
- Diabetes, 2006, v. 55, n. 6, p. 1651, doi. 10.2337/db05-1595
- By:
- Publication type:
- Article
Diabetes-associated mesenteric vascular hypertrophy is attenuated by angiotensin-converting enzyme inhibition.
- Published in:
- 1994
- By:
- Publication type:
- journal article
Role of endothelium-derived nitric oxide in the pathogenesis of the renal hemodynamic changes of experimental diabetes.
- Published in:
- 1994
- By:
- Publication type:
- journal article
Sparsentan is superior to losartan in the gddY mouse model of IgA nephropathy.
- Published in:
- Nephrology Dialysis Transplantation, 2024, v. 39, n. 9, p. 1494, doi. 10.1093/ndt/gfae021
- By:
- Publication type:
- Article
Glomerular endothelial NOS (eNOS) expression in type 2 diabetic patients with nephropathy.
- Published in:
- Nephrology Dialysis Transplantation, 2008, v. 23, n. 9, p. 3037, doi. 10.1093/ndt/gfn174
- By:
- Publication type:
- Article
Effects of xanthine oxidase inhibition with febuxostat on the development of nephropathy in experimental type 2 diabetes.
- Published in:
- 2016
- By:
- Publication type:
- journal article
High ambient glucose augments angiotensin II-induced proinflammatory gene mRNA expression in human mesangial cells: effects of valsartan and simvastatin.
- Published in:
- 2009
- By:
- Publication type:
- journal article